MJ ETF

Towards the end of April, the stock market dropped while bond yields rose due to worries that persistent inflation would lead the Federal Reserve to maintain higher interest rates for an extended period. Just before the Fed's decision, a key measure of US labor costs, closely monitored by policymakers, increased significantly, marking the largest jump in a year.

MJ: Over Diversified Cannabis ETF, But Still A Solid Pick

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA).

This article attempts to assess and rank the relative growth potential of the separate competitors in the cannabis industry. Long-term trends show projected growth in the U.S., Canadian, and global cannabis industries, and it faces a rescheduling catalyst. The article filters through the top revenue-generating cannabis companies in the U.S. and Canada, and ranks them based on weighted analysis.

Investing in the cannabis industry has been challenging due to volatility and lack of federal banking reform. ETFMG Alternative Harvest ETF offers diversified exposure to the cannabis space, but timing is difficult. The future of the industry depends on federal standards and progress on legalization, making it uncertain for sustained confidence.

Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis companies The bill will enable financial institutions including banks to serve the state-legal marijuana companies without the risk of a federal crackdown.

Marijuana-related ETF's are trading higher in September after HHS recommended that the U.S. reclassify and ease restrictions on marijuana.

The prospect of marijuana reclassification has injected newfound optimism into the cannabis investment landscape.

The marijuana industry has not rewarded patient investors as expected, even five years after Canadian legalization and despite hopes for federal legalization in the U.S. History shows that new industries often see a surge of companies emerge, but only a few survive as the industry matures and marijuana investors may have to bear more pain. Popular marijuana ETFs have seen close to 90% drawdown from their all-time highs, with poor returns and high expense ratios, suggesting the industry lacks clear direction.